Find Rubellin B manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Rubellin b, (+)-, 88b20hyo95, Unii-88b20hyo95, 102349-31-5, Benzo(e)naphtho(2',3':5,6)fluoreno(1,9a-b)oxepin-5,10,19(15h)-trione, 5c,8,8a,16-tetrahydro-1,4,8,11,15,18-hexahydroxy-13-methyl-, (5cr,8r,8as,15s,15as)-rel-(+)-, (1s,17r,20r,21s,30s)-5,9,12,20,25,30-hexahydroxy-27-methyl-22-oxaheptacyclo[15.13.0.01,21.03,16.06,15.08,13.024,29]triaconta-3,5,8,10,12,15,18,24(29),25,27-decaene-7,14,23-trione
Molecular Formula
C30H22O10
Molecular Weight
542.5  g/mol
InChI Key
KHJHNXVDMFGVEP-PJQIVZKYSA-N
FDA UNII
88B20HYO95

Rubellin B
Rubellin B has been reported in Mycosphaerella rubella with data available.
1 2D Structure

Rubellin B

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,17R,20R,21S,30S)-5,9,12,20,25,30-hexahydroxy-27-methyl-22-oxaheptacyclo[15.13.0.01,21.03,16.06,15.08,13.024,29]triaconta-3,5,8,10,12,15,18,24(29),25,27-decaene-7,14,23-trione
2.1.2 InChI
InChI=1S/C30H22O10/c1-10-6-12-20(17(34)7-10)29(39)40-28-16(33)3-2-13-19-11(9-30(13,28)27(12)38)8-18(35)23-24(19)26(37)22-15(32)5-4-14(31)21(22)25(23)36/h2-8,13,16,27-28,31-35,38H,9H2,1H3/t13-,16-,27+,28-,30+/m1/s1
2.1.3 InChI Key
KHJHNXVDMFGVEP-PJQIVZKYSA-N
2.2 Other Identifiers
2.2.1 UNII
88B20HYO95
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Rubellin B, (+)-

2. 88b20hyo95

3. Unii-88b20hyo95

4. 102349-31-5

5. Benzo(e)naphtho(2',3':5,6)fluoreno(1,9a-b)oxepin-5,10,19(15h)-trione, 5c,8,8a,16-tetrahydro-1,4,8,11,15,18-hexahydroxy-13-methyl-, (5cr,8r,8as,15s,15as)-rel-(+)-

6. (1s,17r,20r,21s,30s)-5,9,12,20,25,30-hexahydroxy-27-methyl-22-oxaheptacyclo[15.13.0.01,21.03,16.06,15.08,13.024,29]triaconta-3,5,8,10,12,15,18,24(29),25,27-decaene-7,14,23-trione

7. Benzo(e)naphtho(2',3':5,6)fluoreno(1,9a-b)oxepin-5,10,19(15h)-trione, 5c,8,8a,16-tetrahydro-1,4,8,11,15,18-hexahydroxy-13-methyl-, (5c.alpha.,8.beta.,8a.alpha.,15.alpha.,15as*)-(+)-

8. Benzo(e)naphtho(2',3':5,6)fluoreno(1,9a-b)oxepin-5,10,19(15h)-trione, 5c,8,8a,16-tetrahydro-1,4,8,11,15,18-hexahydroxy-13-methyl-, (5calpha,8beta,8aalpha,15alpha,15as*)-(+)-

9. (1s,17r,20r,21s,30s)-5,9,12,20,25,30-hexahydroxy-27-methyl-22-oxaheptacyclo(15.13.0.01,21.03,16.06,15.08,13.024,29)triaconta-3,5,8,10,12,15,18,24(29),25,27-decaene-7,14,23-trione

10. Refchem:180153

11. Chebi:222750

12. Q27269913

2.4 Create Date
2016-05-19
3 Chemical and Physical Properties
Molecular Weight 542.5 g/mol
Molecular Formula C30H22O10
XLogP34
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count10
Rotatable Bond Count0
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area182
Heavy Atom Count40
Formal Charge0
Complexity1140
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty